Peakdale Molecular
High Peak
About Peakdale Molecular
Peakdale Molecular is a contract research organization. It provides drug discovery services to the pharmaceutical, biotech, diagnostics, and materials sciences industries. They operate a comprehensive suite of services for hit-to-lead and lead optimization studies, including early stage ADME. It offers a variety of customized commercial frameworks, from simple fee-for-service to long-term FTE projects. The company provides services such as drug discovery support, nucleoside chemistry, materials chemistry, research support, and business models. Peakdale Molecular was founded in 1992 and is headquartered in High Peak, Derbyshire.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Total funding: $2.0M
- Funding stage: M&A
- Last round: Series Unknown (Jan 2008)
- Website: peakdale.com
- Phone: 44 1298 816 700
Industries & Categories
Medical
Social Profiles
Canonical: https://fsome.com/organization/peakdale-molecular-3812222 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.